INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
MS
Corporate insider

Milligan Sandra

DirectorCIK 0001859810

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score9
Connections with evidence2

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MS
Milligan SandraDirector
GOSSGossamer Bio, Inc.
Grant or award
A—
10.0K sh
Sep 23, 2026Sep 25, 2026
traded Sep 23, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Gossamer Bio, Inc.Director · Jun 5, 2026
  • Insider ofevidence
    Spyre Therapeutics, Inc.Director · May 29, 2026
9
MS
Milligan SandraDirector
GOSSGossamer Bio, Inc.
Grant or award
A
—
115.0K sh
Jun 4, 2026
Jun 5, 2026
traded Jun 4, 2026
+1d
SEC FORM 4

Evidence

9
MS
Milligan SandraDirector
SYRESpyre Therapeutics, Inc.
Grant or award
A—
8,026 sh
May 27, 2026May 29, 2026
traded May 27, 2026
+2dSEC FORM 4

Evidence